SlideShare a Scribd company logo
1 of 55
“Prevention is better than cure”
4/6/2022 1
Dr Anuj Sharma
Preventative strategy – Ca Cervix
Dr Anuj Sharma
4/6/2022 2
Dr Anuj Sharma
Preventative strategy
• Preventable Ca
• Known etiology
• Long natural course of disease
• Preventative strategy
– Social and behavioral changes
– Life style / hygiene
– Vaccination
– Screening
4/6/2022 3
Dr Anuj Sharma
Social and behavioral changes
• Avoid child marriage / early coitarche
• Avoid polygamy
• Barrier contraception
• Personal hygiene
• Proper nutrition/ social uplifting
• Avoid substance abuse
• Immune surveillance management
4/6/2022 4
Dr Anuj Sharma
HPV Vaccines
Types
• HPV 16 & 18 (Cervarix,GSK)
• HPV 16,18,6,11 (Gardasil, Merk,FDA June
2006, Males in 2009)
• HPV 6, 11, 16, 18, 31, 33, 45, 52, and 58
(Nonavalent, Merk, Dec 2014) …….still not
available in India !
4/6/2022 5
Dr Anuj Sharma
Recommended number of
doses
Recommended dosing
schedule
Population
2 0, 6–12 months Persons initiating
vaccination at ages 9
through 14 years, except
immunocompromised
persons
3 0, 1–2, 6 months
(0-2-6 m)
Persons initiating
vaccination at ages 15
through 26 years, and
immunocompromised
persons initiating
vaccination at ages 9
through 26 years
HPV Vaccines
4/6/2022 6
Dr Anuj Sharma
Screening – Ca Cervix
• Down Staging
• Pap Smear & Liquid Based Cytology (LBC)
• HPV DNA
• Colposcopy
– VIA & VILI
4/6/2022 7
Dr Anuj Sharma
Down Staging
• Detection of the disease in an earlier , curable
stage in asymptomatic women ,using simple
speculum examination.
• ASHA/ Aanganwari worker/ ANM
• Trained to diagnosed unhealthy cervix and
refer them to higher health center..
4/6/2022 Dr Anuj Sharma 8
Pap Smear
4/6/2022 9
Dr Anuj Sharma
PAPA OF PAP
Georgios Papanikolaou
4/6/2022 Dr Anuj Sharma 10
Screening of Ca Cervix
• Who should undergo ?
• When should it begin ?
• Why not early screening ?
• Co testing ?
• Exceptions
• Does early intercourse or Vaccination alter the
approach for screening ?
4/6/2022 11
Dr Anuj Sharma
Who Should Undergo
• All Females at the age of 25 yrs onwards
• Discontinue at 65 yrs Provided 3 samples are
negative in last 10 yrs
4/6/2022 12
Dr Anuj Sharma
4/6/2022 Dr Anuj Sharma 13
Why Not Early Screening
• Increase anxiety, morbidity, and expense
• The emotional effect of labeling an
adolescent with a sexually transmitted
infection and potential pre-cancer must be
considered because adolescence is a time of
heightened concern for self-image and
emerging sexuality.
4/6/2022 14
Dr Anuj Sharma
Co Testing
• Preferred
• Performed every 5 yrs
- HPV + Cytology
• cytology alone every 3 y is a acceptable
option
4/6/2022 15
Dr Anuj Sharma
Exceptions
• Women who are infected with HIV (annualy)
• Women who are immunocompromised (such as
those who have received solid organ transplants)
• Women who were exposed to diethylstilbestrol
in utero
• Women previously treated for CIN 2, CIN 3, or
cancer
4/6/2022 16
Dr Anuj Sharma
Commonest Query
Early intercourse and vaccination does not alter
the approach.
4/6/2022 17
Dr Anuj Sharma
Conventional
LBC
Which One Is Better
• Both are same
• Advantage of LBC – Reflex HPV testing can be
done
4/6/2022 20
Dr Anuj Sharma
Interpretation Of Results
• Bethesda System (1 to 7)
• Dysplasia/CIN System (CIN 1,2,3, CIS, SCC)
• Papanicolaou System ( I to V )
4/6/2022 21
Dr Anuj Sharma
• Develops following HPV
infection.
• Clear zone around
nucleus (peri-nuclear
halo)
• Enlarged nucleus
• Increased staining of
nucleus
• Irregularity of nuclear
membrane
• High HPV DNA & Caspid
Antigen
Koilocytosis
4/6/2022 22
Dr Anuj Sharma
Normal Ectocervical Epithelium
Nonkeratinizing, stratified
squamous epithelium.
Mitoses are normally
confined to the lower layers,
namely, the basal and
parabasal epithelial layers.
4/6/2022 Dr Anuj Sharma 23
Low-grade Squamous Intraepithelial Lesion(LSIL)
Disordered proliferation of
squamous cells and increased
mitotic activity confined to the
basal one third of the epithelium.
Koilocytotic atypia, which is
indicative of proliferative HPV
infection, involves the more
superficial epithelium.
Koilocytosis Is nuclear enlargement,
coarse chromatin, nuclear
“wrinkling,” and perinuclear halos
4/6/2022 Dr Anuj Sharma 24
Disordered, highly
atypical squamous cells
and increased mitotic
activity involving the
full thickness of the
epithelium.
Note the mitotic figure
located close to
epithelial surface
(yellow arrow).
4/6/2022 Dr Anuj Sharma 25
High-grade Squamous Intraepithelial Lesion (HSIL)
Bethesda System of Reporting
4/6/2022 26
Dr Anuj Sharma
Bethesda System CIN / Dysplasia Papanicolaou System
Within Normal Limits Normal I Absence of atypical cells
Infection with organism Inflammatory atypia II Atypical cytology
Atypical squamous cells of
undetermined significance
ASCUS-US
Squamous atypia, HPV
atypia, Exclude LSIL
Atypical squamous cells to
exclude high grade lesions
ASCUS-H
HPV atypia
Exclude HSIL
Low-grade squamous
intraepithelial lesion LSIL
Mild dysplasia CIN I
High-grade squamous
intraepithelial lesion HSIL
Moderate dysplasia CIN II III Cytology suggestive of
malignancy but not
conclusive of malignancy
Severe dysplasia CIN III
Carcinoma in-situ
IV Cytology strongly
suggestive of malignancy
Squamous cell carcinoma Squamous cell carcinoma V Cytology conclusive of
malignancy
4/6/2022 27
Dr Anuj Sharma
4/6/2022 28
Dr Anuj Sharma
ASCUS/LSIL
Reflex HPV
Testing Negative
Routine Scrn
Positive
Repeat Cytology
2 X Negative
Routine Screening
Cytology Positive
Colposcopy
Every Year
4/6/2022 29
Dr Anuj Sharma
ASC-H/HSIL (21-24 yrs Age)
Colposcopy
NO CIN 2,3
Observation with Colposcopy
& Cytology @6 months
interval X 2 years
2
Consecutive
Cytology (-)
& NO High
Grade
Colposcopic
Abnormality
Routine
Screening
HSIL / High
Grade
Colposcopic
Lesion
Persists for
1
Year
BIOPSY
CIN
2,3
CIN 2,3
4/6/2022 30
Dr Anuj Sharma
Colposcopy
4/6/2022 Dr Anuj Sharma 31
Colposcopy
• Examination under magnified illumination of the
cervix, vagina and lower ano-genital tract
• Triage of abnormal cytologic, virologic or clinical
findings
• Diagnosing neoplasia in ano-genital tract
• Abnormal or Adjunct to Pap smear / HPV testing
• There should be 80% accuracy rate in colposcopy
& histologic correlation
4/6/2022 32
Dr Anuj Sharma
• No contraindications but may be differed in case of
periods, use of intravaginal products 24 hrs prior to
procedure
• After application of estrogen cream in postmenopausal
women
• Explanation & consent before the procedure
• Transformation Zone
Type 1 - SCJ completely visible
Type 2 – SCJ partly visible
Type 3 - SCJ completely not visible
Colposcopy
4/6/2022 33
Dr Anuj Sharma
4/6/2022 34
Dr Anuj Sharma
Visual Inspection
• VIA – visual inspection with acetic acid
• VILI - visual inspection with lugol’s iodine
4/6/2022 35
Dr Anuj Sharma
VIA
4/6/2022 36
Dr Anuj Sharma
VILI
4/6/2022 37
Dr Anuj Sharma
Colposcopy Interpretation
4/6/2022 38
Dr Anuj Sharma
• ¼ Lugol’s Iodine (Schiller’s Test)
- Rule out allergy history
- Normal ectocervix/vaginal squamous epithelium
(contains glycogen) stains mahogany brown
- Normal columnar/immature or neoplastic
epithelium (no glycogen) stains mustard yellow
Colposcopy Interpretation
4/6/2022 39
Dr Anuj Sharma
Zero Point One Point Two Point
Margin Distinct
Feathery
Angular jagged shape
Regular smooth
Straight edges
Rolled or Peeling
edges
Color Shinny or semi-
transparent whitening
Shinny grey white Dull reflectance
Oyster white
Vessels Fine calibre
Poorly formed pattern
No surface
vessels
Definite coarse
punctation or
mosaic pattern
Iodine Mahogony brown Mottled pattern
or partial iodine
staining
Mustard yellow
staining
Reid’s Colposcopic Index
4/6/2022 40
Dr Anuj Sharma
RCI (overall score) Histology
0 - 2 Likely to be CIN 1
3 - 4 Overlapping lesion: likely to be CIN 1 or
CIN 2
5 - 8 Likely to be CIN 2-3
Reid’s Colposcopic Index
4/6/2022 41
Dr Anuj Sharma
Swede’s Score
4/6/2022 42
Dr Anuj Sharma
Swede’s Score
4/6/2022 43
Dr Anuj Sharma
Management Issues
• ASC-US: repeat cytology/HPV/colposcopy
• ASC-H: colposcopy
• LSIL: repeat cytology(<20Yrs)/ HPV /
colposcopy
• HSIL: colposcopy or excisional procedure
• AGC: colposcopy, endocervical sampling, HPV
DNA, endometrial sampling
• HPV DNA: repeat Pap & colposcopy
4/6/2022 44
Dr Anuj Sharma
Treatment Modalities
• Cryosurgery
• Electro-coagulation Diathermy
• CO2 Laser Excision
• Loop Electrosurgical Excision Procedure LEEP
• Conization
• Hysterectomy
4/6/2022 45
Dr Anuj Sharma
Cryosurgery
• N2O evaporation causes crystallisation of
intracellular water resulting in cellular death
(Freeze-Thaw)
• -65to -85 degree Celsius & 19-25 mm minicone
• 5 mm depth (Equivalent to 7 mm lateral spread)
• Smaller ectocervical lesions with 90 % cure rate
• Watery malodorous blood tinged discharge
4/6/2022 46
Dr Anuj Sharma
Cryosurgery
4/6/2022 47
Dr Anuj Sharma
LEEP
• Cartier, 1990 : Outpatient & Tissue specimen
• Loop Electrodes 1-2 cm width & 0.7-1.5 mm
rectangular thin wire loops & 35-55 W
• 2-3 mm lateral & depth of 5-7 mm of entire TZ
• Ideal specimen dome shaped 5-6mm base to 7-
10 mm center
• Good for lateral lesions & Cure rates 95%
• Complications: bleeding/stenosis/incompetence
4/6/2022 48
Dr Anuj Sharma
LEEP
4/6/2022 49
Dr Anuj Sharma
LEEP
4/6/2022 50
Dr Anuj Sharma
Sequelae
• Vaginal discharge upto 3 weeks
• Minor spotting & secondary bleeding
• Douching, tampon use, SI to be avoided for
next 3-4 weeks
• Repeat Pap & Colposcope at 6 & 12 months
4/6/2022 51
Dr Anuj Sharma
Indications Of Conization
• Unsatisfactory colposcopy
• Entire lesion is not visible
• Discrepancy between cytology & HPE
• ECC is (+) in HSIL
• Microinvasion is suspected
• HPE suspected the adenocarcinoma
4/6/2022 52
Dr Anuj Sharma
Excisional Cervical Conization
4/6/2022 53
Dr Anuj Sharma
• Cure rates for high grade CIN is 95%
• Haemorrhage within 24 Hrs or after 10-21
days
• Rates of stenosis (3%) & incompetence is high
• Persistence is related to lesion
size/grade/extension
Excisional Cervical Conization
4/6/2022 54
Dr Anuj Sharma
सा विद्या या विमुक्तये
4/6/2022 55
Dr Anuj Sharma

More Related Content

What's hot

Endometriosis & adenomyosis
Endometriosis & adenomyosisEndometriosis & adenomyosis
Endometriosis & adenomyosis
raj kumar
 

What's hot (20)

Endometrial cancer JNMCH AMU ALIGARH
Endometrial cancer JNMCH AMU ALIGARHEndometrial cancer JNMCH AMU ALIGARH
Endometrial cancer JNMCH AMU ALIGARH
 
Bartholian cyst
Bartholian cystBartholian cyst
Bartholian cyst
 
Breast lumps
Breast lumpsBreast lumps
Breast lumps
 
Inguinal hernia ppt
Inguinal hernia pptInguinal hernia ppt
Inguinal hernia ppt
 
Benign breast disease
Benign breast diseaseBenign breast disease
Benign breast disease
 
Cin
CinCin
Cin
 
Squamous cell carcinoma skin
Squamous cell carcinoma skinSquamous cell carcinoma skin
Squamous cell carcinoma skin
 
ANDI & benign breast disorders
ANDI & benign breast disordersANDI & benign breast disorders
ANDI & benign breast disorders
 
Benign ovarian tumours
Benign ovarian tumoursBenign ovarian tumours
Benign ovarian tumours
 
Vaginal discharge
Vaginal dischargeVaginal discharge
Vaginal discharge
 
Approach to patient with ovarian cysts
Approach to patient with ovarian cystsApproach to patient with ovarian cysts
Approach to patient with ovarian cysts
 
Screening in Gynecology
Screening in GynecologyScreening in Gynecology
Screening in Gynecology
 
DEBATE - SHORT CERVIX - OS TIGHTNING BY DR SHASHWAT JANI
DEBATE - SHORT CERVIX - OS TIGHTNING BY DR SHASHWAT JANIDEBATE - SHORT CERVIX - OS TIGHTNING BY DR SHASHWAT JANI
DEBATE - SHORT CERVIX - OS TIGHTNING BY DR SHASHWAT JANI
 
Phyllodes tumor
Phyllodes tumorPhyllodes tumor
Phyllodes tumor
 
MANAGEMENT OF VAULT PROLAPSE BY DR SHASHWAT JANI
MANAGEMENT OF VAULT PROLAPSE BY DR SHASHWAT JANIMANAGEMENT OF VAULT PROLAPSE BY DR SHASHWAT JANI
MANAGEMENT OF VAULT PROLAPSE BY DR SHASHWAT JANI
 
Breast carcinoma
Breast carcinomaBreast carcinoma
Breast carcinoma
 
Approach to a patient with breast lump
Approach to a patient with breast lumpApproach to a patient with breast lump
Approach to a patient with breast lump
 
THIRD AND FOURTH DEGREE TEARS
THIRD AND FOURTH DEGREE TEARSTHIRD AND FOURTH DEGREE TEARS
THIRD AND FOURTH DEGREE TEARS
 
Genital warts management
Genital  warts managementGenital  warts management
Genital warts management
 
Endometriosis & adenomyosis
Endometriosis & adenomyosisEndometriosis & adenomyosis
Endometriosis & adenomyosis
 

Similar to Preventative strategy – ca cervix dr anuj sharma

See & treat prog dr. sharda jain
See & treat prog  dr. sharda jainSee & treat prog  dr. sharda jain
See & treat prog dr. sharda jain
Lifecare Centre
 
Cervical Cancer Prevention in Poor Resource areas : See & treatapproach dr. ...
Cervical Cancer Prevention in Poor Resource areas : See & treatapproach  dr. ...Cervical Cancer Prevention in Poor Resource areas : See & treatapproach  dr. ...
Cervical Cancer Prevention in Poor Resource areas : See & treatapproach dr. ...
Lifecare Centre
 
Pprom by dr alka mukherjee dr apurva mukherjee nagpur india
Pprom by dr alka mukherjee dr apurva mukherjee nagpur indiaPprom by dr alka mukherjee dr apurva mukherjee nagpur india
Pprom by dr alka mukherjee dr apurva mukherjee nagpur india
alka mukherjee
 

Similar to Preventative strategy – ca cervix dr anuj sharma (20)

Endometriosis dr anuj sharma
Endometriosis dr anuj sharmaEndometriosis dr anuj sharma
Endometriosis dr anuj sharma
 
A.B.C. of Paps Smear Update (2016) ,DR. SUDHIR JAIN Consultant Pathologist
A.B.C. of Paps Smear Update (2016) ,DR. SUDHIR JAIN  Consultant Pathologist A.B.C. of Paps Smear Update (2016) ,DR. SUDHIR JAIN  Consultant Pathologist
A.B.C. of Paps Smear Update (2016) ,DR. SUDHIR JAIN Consultant Pathologist
 
Ca cervix REVISED FIGO STAGING
Ca cervix REVISED FIGO STAGINGCa cervix REVISED FIGO STAGING
Ca cervix REVISED FIGO STAGING
 
Cervical cancer by dr alka mukherjee dr apurva mukherjee nagpur m.s.
Cervical cancer by dr alka mukherjee dr apurva mukherjee nagpur m.s.Cervical cancer by dr alka mukherjee dr apurva mukherjee nagpur m.s.
Cervical cancer by dr alka mukherjee dr apurva mukherjee nagpur m.s.
 
Fertility preservation in cancer
Fertility preservation in cancer Fertility preservation in cancer
Fertility preservation in cancer
 
Medical management of heavy menstrual bleeding hmb
Medical management of heavy menstrual bleeding hmbMedical management of heavy menstrual bleeding hmb
Medical management of heavy menstrual bleeding hmb
 
Ocular Melanoma Basics and Post Treatment Eye Care - Dan Gombos, MD, FACS
Ocular Melanoma Basics and Post Treatment Eye Care - Dan Gombos, MD, FACSOcular Melanoma Basics and Post Treatment Eye Care - Dan Gombos, MD, FACS
Ocular Melanoma Basics and Post Treatment Eye Care - Dan Gombos, MD, FACS
 
Fertility Enhancing Laparoscopic Surgeries Panel Discussion
Fertility Enhancing Laparoscopic Surgeries Panel DiscussionFertility Enhancing Laparoscopic Surgeries Panel Discussion
Fertility Enhancing Laparoscopic Surgeries Panel Discussion
 
Difficult Cases in IUI
Difficult Cases in IUIDifficult Cases in IUI
Difficult Cases in IUI
 
WEBINAR: Breast Screening and Breast Density
WEBINAR: Breast Screening and Breast DensityWEBINAR: Breast Screening and Breast Density
WEBINAR: Breast Screening and Breast Density
 
See & treat prog dr. sharda jain
See & treat prog  dr. sharda jainSee & treat prog  dr. sharda jain
See & treat prog dr. sharda jain
 
FAMILY PLANNING
FAMILY PLANNINGFAMILY PLANNING
FAMILY PLANNING
 
Cervical Cancer
Cervical CancerCervical Cancer
Cervical Cancer
 
Cervical Cancer Prevention in Poor Resource areas : See & treatapproach dr. ...
Cervical Cancer Prevention in Poor Resource areas : See & treatapproach  dr. ...Cervical Cancer Prevention in Poor Resource areas : See & treatapproach  dr. ...
Cervical Cancer Prevention in Poor Resource areas : See & treatapproach dr. ...
 
Public Health Screening: Programmes and Policy Lecture
Public Health Screening: Programmes and Policy LecturePublic Health Screening: Programmes and Policy Lecture
Public Health Screening: Programmes and Policy Lecture
 
Hysterectomy: The Evidence
Hysterectomy: The EvidenceHysterectomy: The Evidence
Hysterectomy: The Evidence
 
Cin&cancer cervix undergraduate
Cin&cancer cervix undergraduateCin&cancer cervix undergraduate
Cin&cancer cervix undergraduate
 
Pprom by dr alka mukherjee dr apurva mukherjee nagpur india
Pprom by dr alka mukherjee dr apurva mukherjee nagpur indiaPprom by dr alka mukherjee dr apurva mukherjee nagpur india
Pprom by dr alka mukherjee dr apurva mukherjee nagpur india
 
Cervical cancer screening guidelines 2013
Cervical cancer screening guidelines 2013Cervical cancer screening guidelines 2013
Cervical cancer screening guidelines 2013
 
Ca cervix
Ca cervixCa cervix
Ca cervix
 

Recently uploaded

Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdf
Chris Hunter
 
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in DelhiRussian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
kauryashika82
 

Recently uploaded (20)

How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17
 
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
 
Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdf
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
 
On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan Fellows
 
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
 
Role Of Transgenic Animal In Target Validation-1.pptx
Role Of Transgenic Animal In Target Validation-1.pptxRole Of Transgenic Animal In Target Validation-1.pptx
Role Of Transgenic Animal In Target Validation-1.pptx
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.ppt
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.
 
General Principles of Intellectual Property: Concepts of Intellectual Proper...
General Principles of Intellectual Property: Concepts of Intellectual  Proper...General Principles of Intellectual Property: Concepts of Intellectual  Proper...
General Principles of Intellectual Property: Concepts of Intellectual Proper...
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
Micro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfMicro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdf
 
Food Chain and Food Web (Ecosystem) EVS, B. Pharmacy 1st Year, Sem-II
Food Chain and Food Web (Ecosystem) EVS, B. Pharmacy 1st Year, Sem-IIFood Chain and Food Web (Ecosystem) EVS, B. Pharmacy 1st Year, Sem-II
Food Chain and Food Web (Ecosystem) EVS, B. Pharmacy 1st Year, Sem-II
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in DelhiRussian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
 
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
 
Measures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDMeasures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SD
 
PROCESS RECORDING FORMAT.docx
PROCESS      RECORDING        FORMAT.docxPROCESS      RECORDING        FORMAT.docx
PROCESS RECORDING FORMAT.docx
 

Preventative strategy – ca cervix dr anuj sharma

  • 1. “Prevention is better than cure” 4/6/2022 1 Dr Anuj Sharma
  • 2. Preventative strategy – Ca Cervix Dr Anuj Sharma 4/6/2022 2 Dr Anuj Sharma
  • 3. Preventative strategy • Preventable Ca • Known etiology • Long natural course of disease • Preventative strategy – Social and behavioral changes – Life style / hygiene – Vaccination – Screening 4/6/2022 3 Dr Anuj Sharma
  • 4. Social and behavioral changes • Avoid child marriage / early coitarche • Avoid polygamy • Barrier contraception • Personal hygiene • Proper nutrition/ social uplifting • Avoid substance abuse • Immune surveillance management 4/6/2022 4 Dr Anuj Sharma
  • 5. HPV Vaccines Types • HPV 16 & 18 (Cervarix,GSK) • HPV 16,18,6,11 (Gardasil, Merk,FDA June 2006, Males in 2009) • HPV 6, 11, 16, 18, 31, 33, 45, 52, and 58 (Nonavalent, Merk, Dec 2014) …….still not available in India ! 4/6/2022 5 Dr Anuj Sharma
  • 6. Recommended number of doses Recommended dosing schedule Population 2 0, 6–12 months Persons initiating vaccination at ages 9 through 14 years, except immunocompromised persons 3 0, 1–2, 6 months (0-2-6 m) Persons initiating vaccination at ages 15 through 26 years, and immunocompromised persons initiating vaccination at ages 9 through 26 years HPV Vaccines 4/6/2022 6 Dr Anuj Sharma
  • 7. Screening – Ca Cervix • Down Staging • Pap Smear & Liquid Based Cytology (LBC) • HPV DNA • Colposcopy – VIA & VILI 4/6/2022 7 Dr Anuj Sharma
  • 8. Down Staging • Detection of the disease in an earlier , curable stage in asymptomatic women ,using simple speculum examination. • ASHA/ Aanganwari worker/ ANM • Trained to diagnosed unhealthy cervix and refer them to higher health center.. 4/6/2022 Dr Anuj Sharma 8
  • 10. PAPA OF PAP Georgios Papanikolaou 4/6/2022 Dr Anuj Sharma 10
  • 11. Screening of Ca Cervix • Who should undergo ? • When should it begin ? • Why not early screening ? • Co testing ? • Exceptions • Does early intercourse or Vaccination alter the approach for screening ? 4/6/2022 11 Dr Anuj Sharma
  • 12. Who Should Undergo • All Females at the age of 25 yrs onwards • Discontinue at 65 yrs Provided 3 samples are negative in last 10 yrs 4/6/2022 12 Dr Anuj Sharma
  • 13. 4/6/2022 Dr Anuj Sharma 13
  • 14. Why Not Early Screening • Increase anxiety, morbidity, and expense • The emotional effect of labeling an adolescent with a sexually transmitted infection and potential pre-cancer must be considered because adolescence is a time of heightened concern for self-image and emerging sexuality. 4/6/2022 14 Dr Anuj Sharma
  • 15. Co Testing • Preferred • Performed every 5 yrs - HPV + Cytology • cytology alone every 3 y is a acceptable option 4/6/2022 15 Dr Anuj Sharma
  • 16. Exceptions • Women who are infected with HIV (annualy) • Women who are immunocompromised (such as those who have received solid organ transplants) • Women who were exposed to diethylstilbestrol in utero • Women previously treated for CIN 2, CIN 3, or cancer 4/6/2022 16 Dr Anuj Sharma
  • 17. Commonest Query Early intercourse and vaccination does not alter the approach. 4/6/2022 17 Dr Anuj Sharma
  • 19. LBC
  • 20. Which One Is Better • Both are same • Advantage of LBC – Reflex HPV testing can be done 4/6/2022 20 Dr Anuj Sharma
  • 21. Interpretation Of Results • Bethesda System (1 to 7) • Dysplasia/CIN System (CIN 1,2,3, CIS, SCC) • Papanicolaou System ( I to V ) 4/6/2022 21 Dr Anuj Sharma
  • 22. • Develops following HPV infection. • Clear zone around nucleus (peri-nuclear halo) • Enlarged nucleus • Increased staining of nucleus • Irregularity of nuclear membrane • High HPV DNA & Caspid Antigen Koilocytosis 4/6/2022 22 Dr Anuj Sharma
  • 23. Normal Ectocervical Epithelium Nonkeratinizing, stratified squamous epithelium. Mitoses are normally confined to the lower layers, namely, the basal and parabasal epithelial layers. 4/6/2022 Dr Anuj Sharma 23
  • 24. Low-grade Squamous Intraepithelial Lesion(LSIL) Disordered proliferation of squamous cells and increased mitotic activity confined to the basal one third of the epithelium. Koilocytotic atypia, which is indicative of proliferative HPV infection, involves the more superficial epithelium. Koilocytosis Is nuclear enlargement, coarse chromatin, nuclear “wrinkling,” and perinuclear halos 4/6/2022 Dr Anuj Sharma 24
  • 25. Disordered, highly atypical squamous cells and increased mitotic activity involving the full thickness of the epithelium. Note the mitotic figure located close to epithelial surface (yellow arrow). 4/6/2022 Dr Anuj Sharma 25 High-grade Squamous Intraepithelial Lesion (HSIL)
  • 26. Bethesda System of Reporting 4/6/2022 26 Dr Anuj Sharma
  • 27. Bethesda System CIN / Dysplasia Papanicolaou System Within Normal Limits Normal I Absence of atypical cells Infection with organism Inflammatory atypia II Atypical cytology Atypical squamous cells of undetermined significance ASCUS-US Squamous atypia, HPV atypia, Exclude LSIL Atypical squamous cells to exclude high grade lesions ASCUS-H HPV atypia Exclude HSIL Low-grade squamous intraepithelial lesion LSIL Mild dysplasia CIN I High-grade squamous intraepithelial lesion HSIL Moderate dysplasia CIN II III Cytology suggestive of malignancy but not conclusive of malignancy Severe dysplasia CIN III Carcinoma in-situ IV Cytology strongly suggestive of malignancy Squamous cell carcinoma Squamous cell carcinoma V Cytology conclusive of malignancy 4/6/2022 27 Dr Anuj Sharma
  • 29. ASCUS/LSIL Reflex HPV Testing Negative Routine Scrn Positive Repeat Cytology 2 X Negative Routine Screening Cytology Positive Colposcopy Every Year 4/6/2022 29 Dr Anuj Sharma
  • 30. ASC-H/HSIL (21-24 yrs Age) Colposcopy NO CIN 2,3 Observation with Colposcopy & Cytology @6 months interval X 2 years 2 Consecutive Cytology (-) & NO High Grade Colposcopic Abnormality Routine Screening HSIL / High Grade Colposcopic Lesion Persists for 1 Year BIOPSY CIN 2,3 CIN 2,3 4/6/2022 30 Dr Anuj Sharma
  • 32. Colposcopy • Examination under magnified illumination of the cervix, vagina and lower ano-genital tract • Triage of abnormal cytologic, virologic or clinical findings • Diagnosing neoplasia in ano-genital tract • Abnormal or Adjunct to Pap smear / HPV testing • There should be 80% accuracy rate in colposcopy & histologic correlation 4/6/2022 32 Dr Anuj Sharma
  • 33. • No contraindications but may be differed in case of periods, use of intravaginal products 24 hrs prior to procedure • After application of estrogen cream in postmenopausal women • Explanation & consent before the procedure • Transformation Zone Type 1 - SCJ completely visible Type 2 – SCJ partly visible Type 3 - SCJ completely not visible Colposcopy 4/6/2022 33 Dr Anuj Sharma
  • 35. Visual Inspection • VIA – visual inspection with acetic acid • VILI - visual inspection with lugol’s iodine 4/6/2022 35 Dr Anuj Sharma
  • 39. • ¼ Lugol’s Iodine (Schiller’s Test) - Rule out allergy history - Normal ectocervix/vaginal squamous epithelium (contains glycogen) stains mahogany brown - Normal columnar/immature or neoplastic epithelium (no glycogen) stains mustard yellow Colposcopy Interpretation 4/6/2022 39 Dr Anuj Sharma
  • 40. Zero Point One Point Two Point Margin Distinct Feathery Angular jagged shape Regular smooth Straight edges Rolled or Peeling edges Color Shinny or semi- transparent whitening Shinny grey white Dull reflectance Oyster white Vessels Fine calibre Poorly formed pattern No surface vessels Definite coarse punctation or mosaic pattern Iodine Mahogony brown Mottled pattern or partial iodine staining Mustard yellow staining Reid’s Colposcopic Index 4/6/2022 40 Dr Anuj Sharma
  • 41. RCI (overall score) Histology 0 - 2 Likely to be CIN 1 3 - 4 Overlapping lesion: likely to be CIN 1 or CIN 2 5 - 8 Likely to be CIN 2-3 Reid’s Colposcopic Index 4/6/2022 41 Dr Anuj Sharma
  • 44. Management Issues • ASC-US: repeat cytology/HPV/colposcopy • ASC-H: colposcopy • LSIL: repeat cytology(<20Yrs)/ HPV / colposcopy • HSIL: colposcopy or excisional procedure • AGC: colposcopy, endocervical sampling, HPV DNA, endometrial sampling • HPV DNA: repeat Pap & colposcopy 4/6/2022 44 Dr Anuj Sharma
  • 45. Treatment Modalities • Cryosurgery • Electro-coagulation Diathermy • CO2 Laser Excision • Loop Electrosurgical Excision Procedure LEEP • Conization • Hysterectomy 4/6/2022 45 Dr Anuj Sharma
  • 46. Cryosurgery • N2O evaporation causes crystallisation of intracellular water resulting in cellular death (Freeze-Thaw) • -65to -85 degree Celsius & 19-25 mm minicone • 5 mm depth (Equivalent to 7 mm lateral spread) • Smaller ectocervical lesions with 90 % cure rate • Watery malodorous blood tinged discharge 4/6/2022 46 Dr Anuj Sharma
  • 48. LEEP • Cartier, 1990 : Outpatient & Tissue specimen • Loop Electrodes 1-2 cm width & 0.7-1.5 mm rectangular thin wire loops & 35-55 W • 2-3 mm lateral & depth of 5-7 mm of entire TZ • Ideal specimen dome shaped 5-6mm base to 7- 10 mm center • Good for lateral lesions & Cure rates 95% • Complications: bleeding/stenosis/incompetence 4/6/2022 48 Dr Anuj Sharma
  • 51. Sequelae • Vaginal discharge upto 3 weeks • Minor spotting & secondary bleeding • Douching, tampon use, SI to be avoided for next 3-4 weeks • Repeat Pap & Colposcope at 6 & 12 months 4/6/2022 51 Dr Anuj Sharma
  • 52. Indications Of Conization • Unsatisfactory colposcopy • Entire lesion is not visible • Discrepancy between cytology & HPE • ECC is (+) in HSIL • Microinvasion is suspected • HPE suspected the adenocarcinoma 4/6/2022 52 Dr Anuj Sharma
  • 54. • Cure rates for high grade CIN is 95% • Haemorrhage within 24 Hrs or after 10-21 days • Rates of stenosis (3%) & incompetence is high • Persistence is related to lesion size/grade/extension Excisional Cervical Conization 4/6/2022 54 Dr Anuj Sharma
  • 55. सा विद्या या विमुक्तये 4/6/2022 55 Dr Anuj Sharma

Editor's Notes

  1. Georges Papanicolau Aurel Babes